Abstract
By means of a Sephadex G-50 column and anionic exchange HPLC a cerebral cortex soluble fraction (II-E) which highly inhibits neuronal Na+-K+-ATPase activity has been previously obtained. Herein, II-E properties are compared with those of the cardenolide ouabain, the selective and specific Na+, K+-ATPase inhibitor. It was observed that alkali treatment destroyed II-E but not ouabain inhibitory activity. II-E presented a maximal absorbance at 265 nm both at pH 7 and pH 2 which diminished at pH 10. Ouabain showed a maximum at 220 nm which was not altered by alkalinization. II-E was not retained in a C-18 column, indicating its hydrophilic nature, whereas ouabain presented a 26-min retention time in reverse phase HPLC. Therefore, it is concluded that the inhibitory factor present in II-E is structurally different to ouabain.
Similar content being viewed by others
REFERENCES
Stahl, W. L. 1986. The Na+, K+-ATPase of nervous tissue. Neurochem. Int. 4:449–476.
Wu, P. H. 1986. Na+, K+-ATPase in nervous tissue. Pages 451–502, in Boulton, A. A., Baker, G. B., and Wu, P. H. (eds.), Neuromethods, Enzymes, Humana, Clifton, NJ.
Rodriguez de Lores Arnaiz, G., and Mistrorigo de Pacheco, M. 1978. Regulation of (Na+, K+) adenosine triphosphatase of nerve ending membranes: action of norepinephrine and a soluble factor. Neurochem. Res. 3:733–744.
Rodriguez de Lores Arnaiz, G., and Antonelli de Gómez de Lima, M. 1988. The aging of a brain soluble fraction modifies its effect on the activity of neuronal Na+, K+-ATPase. Life Sci. 42:2683–2689.
Rodríguez de Lores Arnaiz, G., and Antonelli de Gómez de Lima, M. 1986. Partial characterization of an endogenous factor which modulates the effect of catecholamines on synaptosomal Na+, K+-ATPase. Neurochem. Res. 11:933–947.
Rodríguez de Lores Arnaiz, G., Antonelli de Gómez de Lima, M., and Girardi, E. 1988. Different properties of two brain fractions separated in Sephadex G-50 that modify synaptosomal ATPase activities. Neurochem. Res. 3:229–235.
Nowicki, S., Enero, M. A., and Rodríguez de Lores Arnaiz, G. 1990. Diuretic and natriuretic effect of a brain soluble fraction that inhibits neuronal Na+, K+-ATPase. Life Sci. 47:1091–1098.
Rodríguez de Lores Arnaiz, G., and Pellegrino de Iraldi, A. 1991. The release of catecholamines by an endogenous factor that inhibits neuronal Na+, K+-ATPase. Micr. Electr. Biol. Cell. 15:93–106.
Antonelli, M., Casillas, T., and Rodríguez de Lores Arnaiz, G. 1991. Effect of Na+, K+ ATPase modifiers on high-affinity ouabain binding determined by quantitative autoradiography. J. Neurosci. Res 28:342–331.
Rodríguez de Lores Arnaiz, G., and Peña, C. 1995. Characterization of synaptosomal membrane Na+, K+-ATPase inhibitors. Neurochem. Int. 27:319–327.
Rodríguez de Lores Arnaiz, G., Alberici, M., and De Robertis, E. 1967. Ultrastructural and enzymic studies of cholinergic and non-cholinergic synpatic membranes isolated from brain cortex. J. Neurochem. 14:215–225.
Albers, R. W., Rodríguez de Lores Arnaiz, G., and De Robertis, E. 1965. Sodium-potassium-activated ATPase and potassium-activated p-nitrophenylphosphatase: a comparison of their subcellular localizations in rat brain. Proc. Natl. Acad. Sci. USA 53:557–564.
Lowry, O. H., Rosebrough., N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Schwartz, A., Lindenmayer, G. E., and Allen, J. C. 1975. The sodium potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects. Pharmacol. Rev. 27:3–134.
Goto, A., Yamada, K., Yagi, N., Yoshioka, M., and Sugimoto, T.: Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol. Rev. 44:377–399.
Rodríguez de Lores Arnaiz, G. 1992. In search of synaptosomal Na+, K+-ATPase regulators. Mol. Neurobiol. 6:359–375.
Hamlyn, J. M., Blaustein, M. P., Bova, S. DuCharme, D. W., Harris, D. W., Mandel F., Mathews, W. R., and Ludens, J. H. 1991. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. USA 88:6259–6263.
Mathews, W. R., DuCharme, D. W., Hamlyn, J. M., Harris, D. W., Mandel, F., Clark, M. A., and Ludens, J. H. 1991. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 17:930–935.
Balzan, S., Ghione, S., Pieraccini, L., Biver, P., Di Bartolo, V., and Montali, U. 1994. Endogenous digitalis-like factor from umbilical cord and ouabain: comparison of biochemical properties. Pages 755–758, in Bamberg, E., and Schoner, W., (eds.), The Sodium Pump, Steinkopff, Darmstadt.
Di Bartolo, V., Balzan, S., Pieraccini, L., Ghione, S., Pegoraro, S., Biver, P., Revoltella, R., and Montali, U. 1995. Evidence for an endogenous ouabain-like immunoreactive factor in human newborn plasma coeluted with ouabain on HPLC. Life Sci. 57:1417–1425.
Tamura, M., Lam, T-T., and Inagami, T. 1988. Isolation and characterization of a specific endogenous Na+, K+-ATPase inhibitor from bovine adrenal. Biochemistry 27:4244–4253.
Goto, A., Ishiguro, T., Yamada, K., Ishii, M., Yoshioka, M., Eguchi, C., Shimora, M., and Sugimoto, T. 1990. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem. Biophys. Res. Commun. 173:1093–1101.
Tymiak, A. A., Norman, J. A., Bolgar, M., DiDonato, G. C., Lee, H., Parker, W. L., Lo, L-C., Berova, N., Nakanishi, K., Haber, E., and Haupert, G. T., Jr. 1993. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc. Natl. Acad. Sci. USA 90:8189–8193.
Tamura, M., Harris, T. M., Konishi, F., and Inagami, T. 1993. Isolation and characterization of an endogenous Na+, K+-ATPase-specific inhibitor from pig urine. Eur. J. Biochem. 211:317–327.
Longerich, L., Johnson, E., and Gault, M. H. 1993. Digoxin-like factors in herbal teas. Clin. Invest. Med. 16:210–218.
Rodríguez de Lores Arnaiz, G. 1993. An endogenous factor which interacts with synaptosomal membrane Na+, K+-ATPase activation by K+. Neurochem. Res. 18:655–661.
Hamlyn, J. M., Ringel, R., Schaeffer, J., Levinson, P. D., Hamilton, B. P., Kowarski, A. A., and Blaustein, M. P. 1982. A circulating inhibitor of (Na+, K+) ATPase associated with essential hypertension. Nature 300:650–652.
Kunes, J., Stolba, P., Pohlova, I., Jelinek, J., and Zicha, J. 1985. The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension. Clin. Exp. Hypert. A7:707.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peña, C., de Lores Arnaiz, G.R. Differential Properties Between an Endogenous Brain Na+, K+-ATPase Inhibitor and Ouabain. Neurochem Res 22, 379–383 (1997). https://doi.org/10.1023/A:1027343323629
Issue Date:
DOI: https://doi.org/10.1023/A:1027343323629